Advertisement
Screener

BIOVENTUS INC. (BVS) Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest

BIOVENTUS INC. Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest

BIOVENTUS INC. (BVS) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of -$54.77 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.

Discontinued › Income Statement

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2023-03-31

  • BIOVENTUS INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$12.63M.
  • BIOVENTUS INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-10-01 was -$37.60M.
  • BIOVENTUS INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-07-02 was -$868.00K.
  • BIOVENTUS INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2022-04-02 was -$3.67M.
  • BIOVENTUS INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2022 was -$54.77M.
  • BIOVENTUS INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2021 was -$9.79M.
  • BIOVENTUS INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2020 was -$1.69M.
  • BIOVENTUS INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2019 was -$553.00K.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month
2022-12-31-$12.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$50.23M
derived: sum of 2 quarters · filed 2023-03-31
-$51.10M
derived: sum of 3 quarters · filed 2023-03-31
-$54.77M
10-K · filed 2023-03-31
2022-10-01-$37.60M
10-Q · filed 2022-11-21
-$38.47M
derived: sum of 2 quarters · filed 2022-11-21
-$42.14M
10-Q · filed 2022-11-21
-$43.74M
derived: sum of 4 quarters · filed 2023-03-31
2022-07-02-$868.00K
10-Q · filed 2022-08-12
-$4.54M
10-Q · filed 2022-08-12
-$6.14M
derived: sum of 3 quarters · filed 2023-03-31
-$7.44M
derived: sum of 4 quarters · filed 2023-03-31
2022-04-02-$3.67M
10-Q · filed 2022-05-11
-$5.28M
derived: sum of 2 quarters · filed 2023-03-31
-$6.58M
derived: sum of 3 quarters · filed 2023-03-31
-$13.22M
derived: sum of 4 quarters · filed 2023-03-31
2021-12-31-$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$2.91M
derived: sum of 2 quarters · filed 2023-03-31
-$9.55M
derived: sum of 3 quarters · filed 2023-03-31
-$9.79M
10-K · filed 2023-03-31
2021-10-02-$1.30M
10-Q · filed 2022-11-21
-$7.95M
derived: sum of 2 quarters · filed 2022-11-21
-$8.18M
10-Q · filed 2022-11-21
-$8.88M
derived: sum of 4 quarters · filed 2023-03-31
2021-07-03-$6.65M
10-Q · filed 2022-08-12
-$6.88M
10-Q · filed 2022-08-12
-$7.58M
derived: sum of 3 quarters · filed 2023-03-31
-$8.07M
derived: sum of 4 quarters · filed 2023-03-31
2021-04-03-$408.00K
10-Q · filed 2022-05-11
-$933.00K
derived: sum of 2 quarters · filed 2023-03-31
-$1.43M
derived: sum of 3 quarters · filed 2023-03-31
-$1.64M
derived: sum of 4 quarters · filed 2023-03-31
2020-12-31-$525.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$1.02M
derived: sum of 2 quarters · filed 2023-03-31
-$1.23M
derived: sum of 3 quarters · filed 2023-03-31
-$1.69M
10-K · filed 2023-03-31
2020-09-26-$492.00K
10-Q · filed 2021-11-10
-$706.00K
derived: sum of 2 quarters · filed 2021-11-10
-$1.16M
10-Q · filed 2021-11-10
2020-06-27-$214.00K
10-Q · filed 2021-08-11
-$672.00K
10-Q · filed 2021-08-11
2019-12-31-$553.00K
10-K · filed 2022-03-11